Cellular Genomics Raises $34.9M in Series C

Cellular Genomics said this week it has raised $34.9 million in a Series C private equity financing round.

The Branford, Conn.-based company, which applies its chemical genetics platform for in-house drug discovery and in collaborations, said it plans to use the funding to advance the in-house programs into the clinic.

In this round, previous investors Coastview Capital and Connecticut Innovations were joined by new investors CDP Capital, RiverVest Venture Partners, and Toucan Capital.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.